AstraZeneca is emerging as a potential new contender in the booming obesity treatment market after its experimental ...
(Reuters) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from ...
Evusheld reduces viral load of all tested Omicron sub-variants -study Also limited lung inflammation in mice lungs Britain approved the preventative COVID therapy last week March 21 (Reuters) - ...
Lab Notes: AstraZeneca enters into another $1B acquisition deal; FDA puts hold on Iovance drug study
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Life sciences industry updates ...
An AstraZeneca lab in England. The Anglo-Swedish company is buying Fusion Pharmaceuticals for up to $2.4 billion.Peter Byrne/Zuma Press AstraZeneca became the latest big pharma to buy a company ...
Drugmaker had stalled large-scale projects in England but has now pledged investment at two sites, announced by Keir Starmer ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This week's Lab Notes has items ...
Dec 23 (Reuters) - A three-dose course of AstraZeneca'sAZN.L COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results